Angelini Labopharm Announces the U.S. Launch of OLEPTRO(TM) for the Treatment of Major Depressive Disorder in Adults
PRINCETON, N.J., Aug. 10 /PRNewswire/ — Angelini Labopharm today announced that OLEPTRO(TM) (trazodone hydrochloride extended-release tablets), a novel once-daily formulation of the antidepressant trazodone, is now commercially available in the United States. OLEPTRO(TM) is indicated for the treatment of major depressive disorder (MDD) in adults. The efficacy of OLEPTRO(TM) has been established …
Pregnancy & Panic Attacks